Local Doctors are Using Super Precise Technology, Gamma Knife, to Help Patients with Brain Tumors
Marc Mosbacher, MD, Radiation Oncologist
December 17, 2020
The radiation oncology experts at OHC are using advanced technology to destroy cancerous brain tumors and give patients an improved chance at a longer remission. In the past, brain tumors were treated with radiation to the entire brain. This resulted... Read More
OHC doctors share preliminary results of a national study on extended use of immunotherapy for advanced non-small cell lung cancer
David M. Waterhouse, MD, MPH, medical oncologist, hematologist and co-director of the department of clinical research at OHC
December 10, 2020
The Journal of Clinical Oncology published an article in its November 2020 issue about a study evaluating the extended use of nivolumab (Opdivo) for certain patients with advanced non-small cell lung cancer (NSCLC). As the lead author of the study, I... Read More
Two Years After its Introduction, Ground-breaking Cancer Treatment CAR-T is Showing Positive Results
E. Randolph Broun, MD, a noted medical oncologist, hematologist and blood and marrow transplant specialist
December 3, 2020
Two years ago, the cancer experts at OHC were the first independent adult cancer group in the region to introduce the revolutionary treatment, CAR T-cell therapy, for adults. Since that noteworthy day, our researchers have made some great strides in... Read More
A Message of Thanks to Our Patients, Their Families and Our Community
the Doctors and Staff at OHC
November 25, 2020
At OHC, we want to acknowledge the kindness and contributions of our patients, their families and the community during the COVID-19 pandemic. Your outpouring of support, especially during the initial height and current spike of the virus, has served... Read More
Cancer and COVID-19: Celebrate Safe Holidays This Season
Prasad R. Kudalkar, MD, medical oncologist and hematologist
November 23, 2020
As COVID screenings increase and positive results trend up, families are faced with difficult decisions about how to safely navigate the holiday season. Those with weakened immune systems, including many cancer patients, are more susceptible to... Read More
Treatment advancements and awareness are giving patients with pancreatic cancer hope
Evan Z. Lang, MD, MS, medical oncologist and hematologist who specializes in the treatment of pancreatic cancer
November 19, 2020
November is Pancreatic Cancer Awareness Month and the cancer experts at OHC believe the more you know about the disease – including risks, symptoms and early detection – as well as advancements in treatments, the better the chance for extended... Read More
Gifts allow breast cancer patients to focus on fun
D. Randolph Drosick, MD, a medical oncologist and hematologist at OHC who serves on the Karen Wellington Foundation Medical Advisory Board
November 12, 2020
For women dealing with breast cancer their lives tend to be consumed by their disease and treatment. At OHC, our team leads patients through their cancer journey with advanced treatments as well as support services and resources to help them manage... Read More
New FDA-approved treatment for lung cancer is available at OHC
Benjamin T. Herms, MD, OHC medical oncologist and hematologist who specializes in lung and genitourinary cancer
November 10, 2020
OHC is excited to share that the US Food and Drug Administration has approved a new treatment for metastatic non-small cell lung cancer. This new treatment, which has been available at OHC since April through its clinical trials, offers these... Read More
Written by Rebecca Hendrixson and photographed by Robert White for Venue magazine. In the spring of 2017, during a routine checkup, Samantha England’s gynecologist found a lump in her left breast. A biopsy was performed, and results came back... Read More
OHC is evaluating a promising new treatment for metastatic HER2-positive breast cancer
Paula Weisenberger, MD, Medical Oncologist and Hematologist at OHC
October 29, 2020
One of every five breast cancers are HER2-positive breast cancers. This type tends to grow and spread faster than other breast cancers but are much more likely to respond to treatments that target the HER2 protein. A recent study reported that women... Read More
